- What is CPT Capital's primary investment thesis?
- CPT Capital, the venture arm of Jeremy Coller's private family office, invests in founders creating the future of food and materials by replacing animals in the supply chain. This includes solutions from plant-based protein to cell-based meat.
- What stages does CPT Capital typically invest in?
- CPT Capital invests from pre-seed onwards, ideally getting involved from pre-seed to Series B, with a view to continually backing companies through to exit.
- Which sectors does CPT Capital primarily focus on?
- CPT Capital predominantly focuses on Agriculture & Food Technologies, with 10 portfolio companies in this sector. They also have investments in Health Tech & Life Sciences and Business Software.
- Can you name some of CPT Capital's notable portfolio companies in the food technology space?
- CPT Capital's portfolio includes Aleph Farms, which focuses on cellular agriculture technology.
- What is CPT Capital's geographic investment focus?
- CPT Capital is open to opportunities across the globe and is actively looking to expand the geographic representation of its portfolio, which is primarily US-focused at present.
- What is CPT Capital's most recent investment activity?
- CPT Capital made an investment in January 2024 and another in October 2023, indicating recent activity in its investment strategy.
- Which portfolio company received a significant Series C investment with CPT Capital's participation?
- Aleph Farms, a cellular agriculture technology company, has raised a total of $147.35M through its Series C funding stage with CPT Capital's involvement.
- Has CPT Capital invested in companies developing animal-free dairy products?
- Yes, CPT Capital has invested in Imagindairy and Remilk, both of which are developing animal-free dairy products.
